학술논문
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
Document Type
Article
Author
Source
In Blood Advances 11 August 2020 4(15):3677-3687
Subject
Language
ISSN
2473-9529